JAML immunotherapy targets recently activated tumor-infiltrating CD8+ T cells.
暂无分享，去创建一个
G. Thomas | P. Vijayanand | C. Ottensmeier | S. Chee | Vivek Chandra | S. Eschweiler | A. von Witzleben | M. Ellis | Hayley Simon | C. Ramírez-Suástegui | Yingcong Li | M. Mondal | Alice Wang